[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fzWr6zdJ-Y59gYRojUWB9XDVsUU_KaOSODSh0ngWSFZQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Glostrup University Hospital, Copenhagen",[4],106,false,5,3,105290,1,78,[14,16,19,21,23,25,27,29],{"name":15,"count":8},"Type 2 Diabetes",{"name":17,"count":18},"Rheumatoid Arthritis",4,{"name":20,"count":18},"Healthy",{"name":22,"count":18},"Cardiovascular Disease",{"name":24,"count":9},"Diabetes Mellitus",{"name":26,"count":9},"Pain, Postoperative",{"name":28,"count":9},"Epiretinal Membrane",{"name":30,"count":9},"Diabetic Retinopathy",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT06792422","A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma","2028-08","Oral semaglutide",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,71,98,116,134,159,187,212,239,257,281,311,336,362,389,416,442,467,510,541,566,589,616,643,661,679,704,722,746,769,795],{"intervention":36,"totalTrials":11,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":69},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":49},[],{"trials":57,"activeCount":11,"soonestReadout":35},[58],{"nctId":33,"briefTitle":34,"status":59,"phases":60,"primaryCompletion":35,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":68},"RECRUITING",[42],"2028-12","2025-01",126,[65,66,67],"Primary Open Angle Glaucoma (POAG)","Open-Angle Glaucoma","Glaucoma",[36],{"trials":70,"activeCount":49},[],{"intervention":72,"totalTrials":11,"cells":73},"paracetamol + placebo + placebo",{"EARLY_PHASE1":74,"PHASE1":76,"PHASE2":78,"PHASE3":80,"PHASE4":82,"NA":96},{"trials":75,"activeCount":49},[],{"trials":77,"activeCount":49},[],{"trials":79,"activeCount":49},[],{"trials":81,"activeCount":49},[],{"trials":83,"activeCount":49},[84],{"nctId":85,"briefTitle":86,"status":87,"phases":88,"primaryCompletion":89,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":93},"NCT00378547","Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy","TERMINATED",[42],"2009-12","2006-01",147,[26],[72,94,95],"paracetamol + pregabalin + placebo","paracetamol + pregabalin + dexamethasone",{"trials":97,"activeCount":49},[],{"intervention":94,"totalTrials":11,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":114},{"trials":101,"activeCount":49},[],{"trials":103,"activeCount":49},[],{"trials":105,"activeCount":49},[],{"trials":107,"activeCount":49},[],{"trials":109,"activeCount":49},[110],{"nctId":85,"briefTitle":86,"status":87,"phases":111,"primaryCompletion":89,"completion":89,"start":90,"enrollment":91,"conditions":112,"interventions":113},[42],[26],[72,94,95],{"trials":115,"activeCount":49},[],{"intervention":95,"totalTrials":11,"cells":117},{"EARLY_PHASE1":118,"PHASE1":120,"PHASE2":122,"PHASE3":124,"PHASE4":126,"NA":132},{"trials":119,"activeCount":49},[],{"trials":121,"activeCount":49},[],{"trials":123,"activeCount":49},[],{"trials":125,"activeCount":49},[],{"trials":127,"activeCount":49},[128],{"nctId":85,"briefTitle":86,"status":87,"phases":129,"primaryCompletion":89,"completion":89,"start":90,"enrollment":91,"conditions":130,"interventions":131},[42],[26],[72,94,95],{"trials":133,"activeCount":49},[],{"intervention":135,"totalTrials":11,"cells":136},"Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity",{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":145,"NA":157},{"trials":138,"activeCount":49},[],{"trials":140,"activeCount":49},[],{"trials":142,"activeCount":49},[],{"trials":144,"activeCount":49},[],{"trials":146,"activeCount":49},[147],{"nctId":148,"briefTitle":149,"status":87,"phases":150,"primaryCompletion":151,"completion":151,"start":152,"enrollment":153,"conditions":154,"interventions":156},"NCT00726804","Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis",[42],"2012-05","2008-03",7,[155],"SPONDYLOARTHRITIS",[135],{"trials":158,"activeCount":49},[],{"intervention":160,"totalTrials":11,"cells":161},"esomeprazole",{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":168,"PHASE4":170,"NA":185},{"trials":163,"activeCount":49},[],{"trials":165,"activeCount":49},[],{"trials":167,"activeCount":49},[],{"trials":169,"activeCount":49},[],{"trials":171,"activeCount":49},[172],{"nctId":173,"briefTitle":174,"status":175,"phases":176,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":184},"NCT00363701","Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice","UNKNOWN",[42],"2008-02","2006-08",150,[181,182,183],"Dyspepsia","Gastroesophageal Refluxdisease","Ulcer",[160],{"trials":186,"activeCount":49},[],{"intervention":188,"totalTrials":11,"cells":189},"Gabapentin + dexamethasone + ketamine",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":210},{"trials":191,"activeCount":49},[],{"trials":193,"activeCount":49},[],{"trials":195,"activeCount":49},[],{"trials":197,"activeCount":49},[],{"trials":199,"activeCount":49},[200],{"nctId":201,"briefTitle":202,"status":87,"phases":203,"primaryCompletion":204,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":209},"NCT00236223","The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery",[42],"2008-04","2008-05","2005-10",48,[26],[188],{"trials":211,"activeCount":49},[],{"intervention":213,"totalTrials":11,"cells":214},"Pregabalin",{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":237},{"trials":216,"activeCount":49},[],{"trials":218,"activeCount":49},[],{"trials":220,"activeCount":49},[],{"trials":222,"activeCount":49},[],{"trials":224,"activeCount":49},[225],{"nctId":226,"briefTitle":227,"status":228,"phases":229,"completion":230,"start":206,"enrollment":231,"conditions":232,"interventions":235},"NCT00235261","Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations","COMPLETED",[42],"2007-06",120,[233,234],"Pain","Postoperative",[213,236],"Dexamethasone",{"trials":238,"activeCount":49},[],{"intervention":236,"totalTrials":11,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":249,"NA":255},{"trials":242,"activeCount":49},[],{"trials":244,"activeCount":49},[],{"trials":246,"activeCount":49},[],{"trials":248,"activeCount":49},[],{"trials":250,"activeCount":49},[251],{"nctId":226,"briefTitle":227,"status":228,"phases":252,"completion":230,"start":206,"enrollment":231,"conditions":253,"interventions":254},[42],[233,234],[213,236],{"trials":256,"activeCount":49},[],{"intervention":258,"totalTrials":11,"cells":259},"Pregabalin; Dexamethasone",{"EARLY_PHASE1":260,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":268,"NA":279},{"trials":261,"activeCount":49},[],{"trials":263,"activeCount":49},[],{"trials":265,"activeCount":49},[],{"trials":267,"activeCount":49},[],{"trials":269,"activeCount":49},[270],{"nctId":271,"briefTitle":272,"status":228,"phases":273,"primaryCompletion":274,"completion":177,"start":275,"enrollment":276,"conditions":277,"interventions":278},"NCT00209495","Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients",[42],"2007-11","2005-06",130,[26],[258],{"trials":280,"activeCount":49},[],{"intervention":282,"totalTrials":11,"cells":283},"Minprostin",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":309},{"trials":285,"activeCount":49},[],{"trials":287,"activeCount":49},[],{"trials":289,"activeCount":49},[],{"trials":291,"activeCount":49},[],{"trials":293,"activeCount":49},[294],{"nctId":295,"briefTitle":296,"status":228,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":308},"NCT01255839","The Balloon Project for Birth Induction",[42],"2005-09","2010-12","2002-12",825,[303,304,305,306,307],"Induction Time","Apgar Score","Admission to Neonatal Unit","Vaginal Delivery","Caesarean Section",[282],{"trials":310,"activeCount":49},[],{"intervention":312,"totalTrials":11,"cells":313},"Injection of Hyaluronan or Saline",{"EARLY_PHASE1":314,"PHASE1":316,"PHASE2":318,"PHASE3":320,"PHASE4":322,"NA":334},{"trials":315,"activeCount":49},[],{"trials":317,"activeCount":49},[],{"trials":319,"activeCount":49},[],{"trials":321,"activeCount":49},[],{"trials":323,"activeCount":49},[324],{"nctId":325,"briefTitle":326,"status":175,"phases":327,"completion":328,"start":329,"enrollment":330,"conditions":331,"interventions":333},"NCT00144820","Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis",[42],"2001-11","1999-05",251,[332],"Osteoarthritis, Knee",[312],{"trials":335,"activeCount":49},[],{"intervention":337,"totalTrials":11,"cells":338},"Kaleorid, 750mg",{"EARLY_PHASE1":339,"PHASE1":341,"PHASE2":343,"PHASE3":345,"PHASE4":347,"NA":360},{"trials":340,"activeCount":49},[],{"trials":342,"activeCount":49},[],{"trials":344,"activeCount":49},[],{"trials":346,"activeCount":49},[],{"trials":348,"activeCount":49},[349],{"nctId":350,"briefTitle":351,"status":228,"phases":352,"primaryCompletion":353,"completion":353,"start":354,"enrollment":355,"conditions":356,"interventions":359},"NCT02380157","Blood Pressure Regulation - Role of Potassium",[42],"2016-12","2015-03",25,[357,358],"Blood Pressure","Hypertension",[337],{"trials":361,"activeCount":49},[],{"intervention":363,"totalTrials":11,"cells":364},"simvastatin",{"EARLY_PHASE1":365,"PHASE1":367,"PHASE2":369,"PHASE3":371,"PHASE4":385,"NA":387},{"trials":366,"activeCount":49},[],{"trials":368,"activeCount":49},[],{"trials":370,"activeCount":49},[],{"trials":372,"activeCount":49},[373],{"nctId":374,"briefTitle":375,"status":175,"phases":376,"primaryCompletion":377,"completion":378,"start":379,"enrollment":380,"conditions":381,"interventions":384},"NCT00261326","Simvastatin Treatment of Patients With Acute Optic Neuritis",[41],"2010-01","2011-05","2006-09",64,[382,383],"Optic Neuritis","Multiple Sclerosis",[363],{"trials":386,"activeCount":49},[],{"trials":388,"activeCount":49},[],{"intervention":390,"totalTrials":11,"cells":391},"Melatonin 4 mg",{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":412,"NA":414},{"trials":393,"activeCount":49},[],{"trials":395,"activeCount":49},[],{"trials":397,"activeCount":49},[],{"trials":399,"activeCount":49},[400],{"nctId":401,"briefTitle":402,"status":228,"phases":403,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":407,"interventions":411},"NCT03478306","Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm",[41],"2021-06-12","2018-03-27",31,[30,408,409,410],"Melatonin","Circadian Dysrhythmia","Circadian Rhythm Sleep Disorder, Unspecified Type",[390],{"trials":413,"activeCount":49},[],{"trials":415,"activeCount":49},[],{"intervention":417,"totalTrials":11,"cells":418},"rhPTH",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":436,"PHASE4":438,"NA":440},{"trials":420,"activeCount":49},[],{"trials":422,"activeCount":49},[],{"trials":424,"activeCount":49},[425],{"nctId":426,"briefTitle":427,"status":428,"phases":429,"primaryCompletion":430,"completion":430,"start":431,"enrollment":49,"conditions":432,"interventions":435},"NCT00741182","Effect of PTH(1-34) Treatment on Fracture Healing in Vivo","WITHDRAWN",[40],"2010-09","2008-10",[433,434],"Shoulder Fractures","Trochanteric Fractures",[417],{"trials":437,"activeCount":49},[],{"trials":439,"activeCount":49},[],{"trials":441,"activeCount":49},[],{"intervention":443,"totalTrials":11,"cells":444},"botulinum toxin type A",{"EARLY_PHASE1":445,"PHASE1":447,"PHASE2":449,"PHASE3":461,"PHASE4":463,"NA":465},{"trials":446,"activeCount":49},[],{"trials":448,"activeCount":49},[],{"trials":450,"activeCount":49},[451],{"nctId":452,"briefTitle":453,"status":175,"phases":454,"primaryCompletion":455,"completion":455,"start":456,"enrollment":457,"conditions":458,"interventions":460},"NCT00770406","Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence",[39,40],"2010-06","2009-01",20,[459],"Urge Urinary Incontinence",[443],{"trials":462,"activeCount":49},[],{"trials":464,"activeCount":49},[],{"trials":466,"activeCount":49},[],{"intervention":468,"totalTrials":9,"cells":469},"Adalimumab",{"EARLY_PHASE1":470,"PHASE1":472,"PHASE2":474,"PHASE3":476,"PHASE4":478,"NA":500},{"trials":471,"activeCount":49},[],{"trials":473,"activeCount":49},[],{"trials":475,"activeCount":49},[],{"trials":477,"activeCount":49},[],{"trials":479,"activeCount":49},[480,490],{"nctId":481,"briefTitle":482,"status":228,"phases":483,"primaryCompletion":484,"completion":484,"start":485,"enrollment":486,"conditions":487,"interventions":489},"NCT01465438","HUmira in Psoriatic Arthritis",[42],"2011-06","2006-11",42,[488],"Psoriatic Arthritis",[468],{"nctId":491,"briefTitle":492,"status":175,"phases":493,"primaryCompletion":456,"completion":494,"start":495,"enrollment":496,"conditions":497,"interventions":499},"NCT00477893","Danish Multicenter Study of Adalimumab in Spondyloarthritis",[42],"2013-01","2006-02",52,[498],"Spondyloarthritis",[468],{"trials":501,"activeCount":49},[502],{"nctId":503,"briefTitle":504,"status":228,"phases":505,"primaryCompletion":506,"completion":506,"start":89,"enrollment":507,"conditions":508,"interventions":509},"NCT01029613","Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers",[],"2013-07",40,[17],[468],{"intervention":511,"totalTrials":512,"cells":513},"GLP-2",2,{"EARLY_PHASE1":514,"PHASE1":516,"PHASE2":518,"PHASE3":520,"PHASE4":522,"NA":524},{"trials":515,"activeCount":49},[],{"trials":517,"activeCount":49},[],{"trials":519,"activeCount":49},[],{"trials":521,"activeCount":49},[],{"trials":523,"activeCount":49},[],{"trials":525,"activeCount":49},[526,534],{"nctId":527,"briefTitle":528,"status":175,"phases":529,"enrollment":530,"conditions":531,"interventions":533},"NCT00673751","Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome",[43],8,[532],"Short Bowel Syndrome",[511],{"nctId":535,"briefTitle":536,"status":175,"phases":537,"start":90,"enrollment":538,"conditions":539,"interventions":540},"NCT00273000","The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans",[43],10,[20],[511],{"intervention":542,"totalTrials":11,"cells":543},"Glycerol",{"EARLY_PHASE1":544,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":552,"NA":554},{"trials":545,"activeCount":49},[],{"trials":547,"activeCount":49},[],{"trials":549,"activeCount":49},[],{"trials":551,"activeCount":49},[],{"trials":553,"activeCount":49},[],{"trials":555,"activeCount":49},[556],{"nctId":557,"briefTitle":558,"status":228,"phases":559,"primaryCompletion":495,"completion":560,"start":561,"enrollment":562,"conditions":563,"interventions":565},"NCT00333671","Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)",[43],"2007-04","2004-12",15,[564],"Diabetic Macular Oedema",[542],{"intervention":567,"totalTrials":11,"cells":568},"Galactose, intravenous",{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":575,"PHASE4":577,"NA":579},{"trials":570,"activeCount":49},[],{"trials":572,"activeCount":49},[],{"trials":574,"activeCount":49},[],{"trials":576,"activeCount":49},[],{"trials":578,"activeCount":49},[],{"trials":580,"activeCount":49},[581],{"nctId":582,"briefTitle":583,"status":87,"phases":584,"completion":585,"start":586,"enrollment":11,"conditions":587,"interventions":588},"NCT00427986","Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema",[43],"2007-03","2007-01",[564],[567],{"intervention":590,"totalTrials":11,"cells":591},"Prostacyclin, PGI2",{"EARLY_PHASE1":592,"PHASE1":594,"PHASE2":596,"PHASE3":598,"PHASE4":600,"NA":602},{"trials":593,"activeCount":49},[],{"trials":595,"activeCount":49},[],{"trials":597,"activeCount":49},[],{"trials":599,"activeCount":49},[],{"trials":601,"activeCount":49},[],{"trials":603,"activeCount":49},[604],{"nctId":605,"briefTitle":606,"status":175,"phases":607,"completion":608,"start":609,"enrollment":610,"conditions":611,"interventions":615},"NCT00510172","Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2",[43],"2007-09","2006-12",12,[612,613,614],"Headache","Migraine","Vasodilatation",[590],{"intervention":617,"totalTrials":11,"cells":618},"Latanoprost",{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":627,"NA":629},{"trials":620,"activeCount":49},[],{"trials":622,"activeCount":49},[],{"trials":624,"activeCount":49},[],{"trials":626,"activeCount":49},[],{"trials":628,"activeCount":49},[],{"trials":630,"activeCount":49},[631],{"nctId":632,"briefTitle":633,"status":228,"phases":634,"primaryCompletion":635,"completion":635,"start":636,"enrollment":637,"conditions":638,"interventions":640},"NCT02522039","Pupillary Response After Glaucoma Medication",[43],"2014-11","2014-05",21,[639],"Drug Effect (Glaucoma Drugs)",[617,641,642],"Timolol","Dorzolamide",{"intervention":641,"totalTrials":11,"cells":644},{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":651,"PHASE4":653,"NA":655},{"trials":646,"activeCount":49},[],{"trials":648,"activeCount":49},[],{"trials":650,"activeCount":49},[],{"trials":652,"activeCount":49},[],{"trials":654,"activeCount":49},[],{"trials":656,"activeCount":49},[657],{"nctId":632,"briefTitle":633,"status":228,"phases":658,"primaryCompletion":635,"completion":635,"start":636,"enrollment":637,"conditions":659,"interventions":660},[43],[639],[617,641,642],{"intervention":642,"totalTrials":11,"cells":662},{"EARLY_PHASE1":663,"PHASE1":665,"PHASE2":667,"PHASE3":669,"PHASE4":671,"NA":673},{"trials":664,"activeCount":49},[],{"trials":666,"activeCount":49},[],{"trials":668,"activeCount":49},[],{"trials":670,"activeCount":49},[],{"trials":672,"activeCount":49},[],{"trials":674,"activeCount":49},[675],{"nctId":632,"briefTitle":633,"status":228,"phases":676,"primaryCompletion":635,"completion":635,"start":636,"enrollment":637,"conditions":677,"interventions":678},[43],[639],[617,641,642],{"intervention":680,"totalTrials":11,"cells":681},"Pituitary Adenylate Cyclase-Activating Polypeptide-38",{"EARLY_PHASE1":682,"PHASE1":684,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":692},{"trials":683,"activeCount":49},[],{"trials":685,"activeCount":49},[],{"trials":687,"activeCount":49},[],{"trials":689,"activeCount":49},[],{"trials":691,"activeCount":49},[],{"trials":693,"activeCount":49},[694],{"nctId":695,"briefTitle":696,"status":228,"phases":697,"primaryCompletion":698,"completion":698,"start":378,"enrollment":699,"conditions":700,"interventions":702},"NCT01471990","Effect of PACAP38\u002FVIP on Migraineurs Measured by Magnetic Resonance",[43],"2012-06",24,[701],"Migraine Without Aura",[680,703],"Vasoactive Intestinal Peptide",{"intervention":703,"totalTrials":11,"cells":705},{"EARLY_PHASE1":706,"PHASE1":708,"PHASE2":710,"PHASE3":712,"PHASE4":714,"NA":716},{"trials":707,"activeCount":49},[],{"trials":709,"activeCount":49},[],{"trials":711,"activeCount":49},[],{"trials":713,"activeCount":49},[],{"trials":715,"activeCount":49},[],{"trials":717,"activeCount":49},[718],{"nctId":695,"briefTitle":696,"status":228,"phases":719,"primaryCompletion":698,"completion":698,"start":378,"enrollment":699,"conditions":720,"interventions":721},[43],[701],[680,703],{"intervention":723,"totalTrials":11,"cells":724},"Alemtuzumab",{"EARLY_PHASE1":725,"PHASE1":727,"PHASE2":729,"PHASE3":731,"PHASE4":733,"NA":735},{"trials":726,"activeCount":49},[],{"trials":728,"activeCount":49},[],{"trials":730,"activeCount":49},[],{"trials":732,"activeCount":49},[],{"trials":734,"activeCount":49},[],{"trials":736,"activeCount":49},[737],{"nctId":738,"briefTitle":739,"status":175,"phases":740,"primaryCompletion":741,"completion":741,"start":742,"enrollment":743,"conditions":744,"interventions":745},"NCT03193086","The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients",[],"2020-03-31","2017-01-01",35,[383],[723],{"intervention":747,"totalTrials":11,"cells":748},"Prednisolone",{"EARLY_PHASE1":749,"PHASE1":751,"PHASE2":753,"PHASE3":755,"PHASE4":757,"NA":759},{"trials":750,"activeCount":49},[],{"trials":752,"activeCount":49},[],{"trials":754,"activeCount":49},[],{"trials":756,"activeCount":49},[],{"trials":758,"activeCount":49},[],{"trials":760,"activeCount":49},[761],{"nctId":762,"briefTitle":763,"status":228,"phases":764,"primaryCompletion":455,"completion":455,"start":765,"enrollment":538,"conditions":766,"interventions":768},"NCT01140932","The Electroretinogram in Healthy and Glucose Intolerant Young Men",[43],"2010-02",[767],"Electroretinography",[747],{"intervention":770,"totalTrials":11,"cells":771},"Endothelin-1",{"EARLY_PHASE1":772,"PHASE1":774,"PHASE2":776,"PHASE3":778,"PHASE4":780,"NA":782},{"trials":773,"activeCount":49},[],{"trials":775,"activeCount":49},[],{"trials":777,"activeCount":49},[],{"trials":779,"activeCount":49},[],{"trials":781,"activeCount":49},[],{"trials":783,"activeCount":49},[784],{"nctId":785,"briefTitle":786,"status":175,"phases":787,"primaryCompletion":788,"completion":789,"start":790,"enrollment":791,"conditions":792,"interventions":794},"NCT02906085","Endothelin-1 as a Potential Trigger of Migraine Aura",[43],"2018-05","2019-12","2016-10",60,[793],"Migraine With Aura",[770],{"intervention":796,"totalTrials":11,"cells":797},"vaginal electrical stimulator",{"EARLY_PHASE1":798,"PHASE1":800,"PHASE2":802,"PHASE3":804,"PHASE4":806,"NA":808},{"trials":799,"activeCount":49},[],{"trials":801,"activeCount":49},[],{"trials":803,"activeCount":49},[],{"trials":805,"activeCount":49},[],{"trials":807,"activeCount":49},[],{"trials":809,"activeCount":49},[810],{"nctId":811,"briefTitle":812,"status":228,"phases":813,"primaryCompletion":814,"completion":814,"start":815,"enrollment":816,"conditions":817,"interventions":820},"NCT02427230","Treatment of Urinary Incontinence in Women With Spinal Cord Injury",[43],"2017-03","2015-05",27,[818,819],"Spinal Cord Injury","Urinary Incontinence",[796]]